| 1. Efficacy of Nutritioned Intervention with Nutritional Suspensions in Patients with Severe Stroke |
Page:1713—1715 |
| 2. Influence of Bailing Capsules Combined with Breviscapine Injections on Micro-inflamation in Patients with Peritoneal Dialysis |
Page:1705—1707 |
| 3. Curative Effect of r IL-2 Combined with Cisplatin in the Treatment of Patients with Malignant Pleural Ef-fusions |
Page:1698—1699 |
| 4. Investigation of Resources and Varieties of Coptis Crude Drug Original Plant on Chinese Market |
Page:1691—1695 |
| 5. Rationality Analysis of Thimerosal Content in Chloramphenicol Eye Drops |
Page:1687—1690 |
| 6. Moisture Proof of Membrane-coating Sirolimus Dropping Pills |
Page:1677—1679 |
| 7. Determination of Residual Solvents in Clindamycin Hydrochloride by Headspace Gas Chromatography |
Page:1784—1785 |
| 8. Determination of Benzalkonium Chloride in Compound Aspartate, Vitamin B6 and Dipotassium Glycyrrhe-tate Eye Drops |
Page:1778—1779 |
| 9. Application of Polysorbate 80 in Microbial Limit Test |
Page:1776—1777 |
| 10. Determination of Stilbence Glucoside in Polygonum Multiflorum by HPLC |
Page:1774—1775 |
| 11. Content Change of Icariin in Rujiling Granules after Ray Irradiation |
Page:1768—1769 |
| 12. Study on Cytotoxicity of Codeine Phosphate Tablets |
Page:1763—1764 |
| 13. Review and Analysis of Processing Technology and Active Ingredients of Medicinal Leech |
Page:1760—1762 |
| 14. Classified Summary of Main Components in Eucommia Ulmoides |
Page:1756—1760 |
| 15. Research Progress in Dosage Forms of Tetrandrine |
Page:1753—1756 |
| 16. Analysis on Chemical Substances Illegally Added in TCM and Health Products |
Page:1749—1753 |
| 17. Sedative Effect of Different Doses of Dexmedetomidine in Patients Undergoing Total Abdominal Hyserectomy |
Page:1744—1747 |
| 18. Pharmaceutical Care for One Patient with Chronic Obstructive Pulmonary Disease |
Page:1738—1740 |
| 19. Pharmaceutical Care for a Postoperative Patient with Intracranial Glioma Treated by Chemotherapy |
Page:1731—1733 |
| 20. Breakthrough Points of Pharmaceutical Care in Anti-infection Treatment by Clinical Pharmacists |
Page:1724—1728 |
| 21. Application Investigation of Xiyanping Injections in Bone Surgery Department Inpatients in a Certain Hos-pital |
Page:1720—1722 |
| 22. Efficacy of Paishi Granules on Promoting Stone Expulsion after Extracorporeal Shock Wave Lithotripsy |
Page:1718—1720 |
| 23. Clinical Effects of Sodium Hyaluronate Combined with Arthroscopic Debridement on Knee Osteoarthritis |
Page:1716—1718 |
| 24. Preparation Process of Compound Asiaticoside Gel Plasters |
Page:1672—1674 |
| 25. Determination of Chloramphenicol Vaginal Tablets by HPLC |
Page:1788—1789 |
| 26. Determination of Viterxin in Stenoloma Chusana(L.) Citing |
Page:1786—1787 |
| 27. Determination of Thymol in Thymol Alcoholic Solutions by HPLC |
Page:1782—1783 |
| 28. Determination of AsperosaponinⅥ in Dieda Cuyu Tablets by HPLC |
Page:1770—1772 |
| 29. Study on Quality Standard for Shule Granules |
Page:1765—1767 |
| 30. Effect of Integrated Pharmaceutical Care on Rational Drug Use in Patients Treated with Ambulatory Chemotherapy |
Page:1729—1731 |
| 31. Meta-analysis of Capecitabine-platinum and S-1-platinum in the Treatment of Advanced Gastric Cancer |
Page:1707—1713 |
| 32. Clinical Characters Analysis of Patients with Drug-induced Liver Injury Combined with Hepatitis B |
Page:1702—1704 |
| 33. Optimization of β-Cyclodextrin Inclusion Process for Volatile Oil in Yingxinning Capsules by Orthogonal Test |
Page:1680—1681 |
| 34. A Fast Determination Method for Phenolphthalein Illegally Added into Diet Health Products by Raman Spectroscopy |
Page:1675—1677 |
| 35. Comparative Analysis of Volatile Oil Content in Leaves, Rhizomes and Tuberous Roots of Cureuma Wang-siensis. S. G. Lee et C. F. Liang by GC/MS |
Page:1659—1661 |
| 36. Determination of Related Substances in Asenapine Maleate by HPLC |
Page:1655—1659 |
| 37. Anti-inflammatory and Analgesic Effects of Different Extracts of Folium Pyrrosiae |
Page:1642—1644 |
| 38. Effect of Gingko Flavonoids on Cardiac Function and Contents of SOD and MDA in Myocardial Tissue in Rats with Heart Failure |
Page:1637—1639 |
| 39. Optimization of Semi-bionic Extraction Technology of Forsythia Suspensa by Uniform Design |
Page:1633—1636 |
| 40. Assistant Effects of Longman Ampelopsis Grossedentata on Serum Lipid |
Page:1631—1633 |
| 41. Preparation and in vitro Transdermal Penetration of Capsaicin Liposomes |
Page:1622—1626 |
| 42. Effects of Capsaicin on Rat Cytochrome P450 Isoforms by Cocktail Probe Drug Method |
Page:1613—1619 |
| 43. Effect of Pomegranate Tannins on Endogenous Metabolites in Rat Urine |
Page:1609—1612 |
| 44. Optimization of Water Decocting Extraction Procedures for Ganyankang Capsules with Orthogonal Design |
Page:1662—1665 |
| 45. Determination of Enantiomer in Rivaroxaban by HPLC |
Page:1629—1631 |
| 46. Efficacy and Safety of Azithromycin Combined with Mosapride in Patients with Diabetic Gastroparesis |
Page:1700—1701,1702 |
| 47. Study on Heavy Metal Residues in 100 Chinese Traditional Medicine Materials |
Page:1696—1697,1704 |
| 48. Determination of Two Ingredients in Losartan Potassium and Hydrochlorothiazide Tablets by HPLC |
Page:1684—1686,1683 |
| 49. Studies on Determination Conditions for Reducing End of Hydroxyethyl Starch by DNS Spectrophotometry |
Page:1772—1773,1774 |
| 50. Reflection on Opening of Section for Outpatients for Risk Assessment and Communication of Medication Use in Pregnancy by Pharmacists |
Page:1733—1735,1736 |
| 51. Simultaneous Determination of Gallic Acid and Berberine Hydrochloride in Dihuang Sprays by HPLC |
Page:1682—1683,1686 |
| 52. Preparation and in vitro Drug Release of Betahistine Dihydrochloride Sustained-release Matrix Tablets |
Page:1665—1668,1669 |
| 53. Determination of Ochratoxin A in Chinese Herbs by HPLC-MS/MS |
Page:1652—1654,1655 |
| 54. Rapid Identification and Determination of Gatifloxacin Injections by Raman Spectroscopy |
Page:1626—1628,1648 |
| 55. Investigation of Pharmacokinetics and Bioequivalence of Mecobalamin in Healthy Volunteers by Chemilu-minescent Microparticle Immunoassay |
Page:1619—1621,1622 |
